This paper presents a short review of the available carcinogenicity tests which have been carried out on various phthalate esters prior to the availability of the National Cancer Institute bioassay studies. All 
The first experiment was carried out in 1953 in Sherman rats. Groups of 32 male and 32 female rats were administered 0.04, 0.13 or 0.4% DEHP in the diet for a maximum of two years. The doses were equivalent to 0. 20, 60 and 200 mg/kg body weight/day, respectively. Controls (number unspecified) received basal diet alone. After one year, 42% of the control rats and the same percentage of rats at the highest dose level survived. The various groups were reduced to a maximum of eight males and eight females per group at the end of one year. Two groups of 32 males and 32 females (F1 progeny) were generated from the control and high dose P generation and at 15 days of age were maintained at a dose level of 0.4% DEHP in the diet for one year, at which time the animals were killed. Some tumors were observed in the animals surviving longer than a year, but they were equally scattered among the different groups, so that, on the basis of this experiment, it was not possible to conclude either a negative or positive carcinogenic response to this chemical (2) . The Butyl benzyl phthalate was administered to a group of 20 male and 20 female Wistar rats at a dose of 5 mg/kg body weight/day (exact route and length of treatment unspecified). There was 100% survival at two years. Nontumorous pathological changes were reported to occur in the kidney as well as atrophy of the testes, but no tumors were observed. No details were given concerning control rats, which makes this experiment (6) difficult to evaluate.
Ethyl Phthalylethyl Glycolate
Ethyl phthalylethyl glycolate was administered to Wistar rats at doses of 0.05, 0.5 and 5% in the diet for a period of two years. No difference in survival occurred between the two lowest dose groups and the controls (exact survival times not reported), whereas none of the animals in the 5% dose group survived longer than 72 weeks. In this experiment, no tumors were observed, but some kidney pathology was observed in the highest dose group (7). The lack of details on survival makes this experiment impossible to evaluate.
Butyl Phthalylbutyl Glycolate
Butyl phthalylbutyl glycolate was administered to groups of 20 Sherman rats (sex unspecified) at three dose levels (200, 2000 and 20,000 mg/kg body weight) in the diet for two years. A group of 40 controls received the basal diet. Although no tumors were reported to occur, more than 80 rats were killed before the end of the observation period, and it is difficult to assess the number of animals surviving or at risk to develop tumors (8) .
In conclusion, these various experiments do not allow any evaluation of the carcinogenicity of these chemicals in mice or rats.
